Go Back
AbCellera Biologics
AbCellera Biologics, a venture fund based in Vancouver, Canada, focuses on Series B, Series C, and Series D investments in the BioTech and PetTech sectors. Founded in 2012, the fund, led by Partner Tatiana Solis, has made 2 investments, including Invetx. AbCellera Biologics specializes in developing antibody therapeutics to enhance patient outcomes. For more information, visit their website at www.abcellera.com.
About
About
About
Bio
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Location
Vancouver, Canada
Stage
Series B, Series C, Series D
Partner name
Tatiana Solis
Bio
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Location
Vancouver, Canada
Stage
Series B, Series C, Series D
Partner name
Tatiana Solis
Fund
Fund
Fund
Fund Focus
BioTech, PetTech
Number of investments
2
Number of exits
0
Fund Type
Venture Fund
Portfolio Companies
Invetx
AbCellera Biologics
AbCellera Biologics, a venture fund based in Vancouver, Canada, focuses on Series B, Series C, and Series D investments in the BioTech and PetTech sectors. Founded in 2012, the fund, led by Partner Tatiana Solis, has made 2 investments, including Invetx. AbCellera Biologics specializes in developing antibody therapeutics to enhance patient outcomes. For more information, visit their website at www.abcellera.com.
About
Bio
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Location
Vancouver, Canada
Stage
Series B, Series C, Series D
Partner name
Tatiana Solis
Fund
Fund Focus
BioTech, PetTech
Number of investments
2
Number of exits
0
Fund Type
Venture Fund
Portfolio Companies
Invetx